Artificial Intelligence in Pharmaceuticals, Biologics, and Medical Devices: Present and Future Regulatory Models

Authors

David W. Opderbeck, Seton Hall University Law SchoolFollow

Keywords

artificial intelligence; AI; medical; pharmaceutical

Abstract

Artificial intelligence (AI) and AI-assisted technologies are set to transform the pharmaceutical, biologic, and medical device industries. AI is accelerating a convergence in the pharmaceutical and medical device industries and, in the health-care industry more broadly, is similar to the convergence of the media, entertainment, and communications industries.

Recommended Citation

David W. Opderbeck, Artificial Intelligence in Pharmaceuticals, Biologics, and Medical Devices: Present and Future Regulatory Models, 88 Fordham L. Rev. 553 (2019).
Available at: https://ir.lawnet.fordham.edu/flr/vol88/iss2/7